Our demonstration that deletion of tumor cell COX-2 can enhancetumor-associated CD8+ cytotoxic immune cell infiltration and function mayopen new avenues to develop targeted strategies for COX-2 inhibition in combination withcytotoxic drugs. Here, CD8A is linked to neoplasm.